Clinical Trials Sponsored by AstraZeneca

Total 4307 results

AstraZeneca

Completed

Statins and Risk of Myocardial Infarction in Real Life in France

Myocardial Infarction

France
AstraZeneca

Completed

To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days

Healthy

United States
AstraZeneca

Terminated

Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

Type 2 Diabetes

Sweden
AstraZeneca

Terminated

AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects (JMAD)

Healthy

United States
AstraZeneca

Completed

14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations

Reflux Episodes

Netherlands
AstraZeneca

Completed

The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire (MIGHT)

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (Preedom)

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) (PHENIX)

Gastroesophageal Reflux Disease

Croatia
AstraZeneca

Completed

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

Gastroesophageal Reflux Disease

Vietnam
AstraZeneca

Completed

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

Solid Tumors

United States
AstraZeneca

Terminated

Analysis of Antihypertensive Treatment Efficacy (ATACA)

Arterial Hypertension

Russian Federation
AstraZeneca

Completed

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

Hyperlipidemias

Taiwan
AstraZeneca

Terminated

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects (JSMAD)

Healthy

United Kingdom
AstraZeneca

Completed

Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke (SAPIENCE)

Hypertension

Korea, Republic of
AstraZeneca

Completed

Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin

Healthy Volunteers | Pharmacokinetics

Germany
AstraZeneca

Completed

Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia (CEPHEUS)

Hypercholesterolemia

Korea, Republic of, Vietnam, Malaysia, Taiwan, Philippines, China, Indonesia, Thailand
AstraZeneca

Completed

AZD6140 Oral Contraceptive Interaction Study

Healthy

United States
AstraZeneca

Completed

A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers

Healthy Volunteers

Germany
AstraZeneca

Completed

AZD5672 Absolute Bioavailability Study

Healthy Volunteers

United Kingdom
AstraZeneca

Completed

COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus (COMBAT)

Hypertension

Korea, Republic of
AstraZeneca

Withdrawn

Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects

Healthy Volunteers

United Kingdom
AstraZeneca

Completed

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

Zollinger-Ellison Syndrome

United States, France
AstraZeneca

Terminated

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
AstraZeneca

Completed

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Gastroesophageal Reflux Disease (GERD)

United States, France, Italy, Canada
AstraZeneca

Completed

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

Heart Failure, Congestive

Australia
AstraZeneca

Completed

Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers (ADME)

Healthy
AstraZeneca

Completed

Seroquel XR in Schizophrenia Relapse Prevention

Schizophrenia Relapse Prevention

Hungary
AstraZeneca

Completed

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Advanced Breast Cancer

Japan
AstraZeneca

Completed

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Ischemic Attack, Transient | Cerebral Stroke

United Kingdom, Sweden
AstraZeneca

Completed

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

Heart Failure | Rosuvastatin | Positron Emission Tomography (PET)

Netherlands
AstraZeneca

Completed

Food Effect Study of a Single Dose of ZD4054 (Zibotentan)

Healthy Volunteers

United Kingdom
AstraZeneca

Completed

Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics (Xperience)

Schizophrenia

Netherlands
AstraZeneca

Completed

Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study (GQS)

Gastroesophageal Reflux Disease

Malaysia
AstraZeneca

Completed

Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs (CIMT)

Cardiovascular Disease

Korea, Republic of, Vietnam, Philippines, China, India, Indonesia, Malaysia, Taiwan, Thailand
AstraZeneca

Terminated

Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects

Thrombin Inhibition

United States
AstraZeneca

Completed

Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France

Cardiovascular Risk

France
AstraZeneca

Completed

A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses

Healthy Men

Sweden
AstraZeneca

Completed

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria (CEPHEUS)

Dyslipidemia

Bulgaria
AstraZeneca

Completed

A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions

Healthy

Sweden
AstraZeneca

Completed

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Primary Hypertension

Romania
AstraZeneca

Completed

Management of Diabetes Mellitus Patients With Retinopathy

Diabetes Mellitus | Retinopathy

Switzerland
AstraZeneca

Completed

4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (ROBIN)

Mild to Moderate Alzheimer's Disease

Czech Republic, Hungary, Slovakia
AstraZeneca

Completed

AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects

Healthy

United States
AstraZeneca

Completed

Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients (VITALITE)

Chronic Obstructive Pulmonary Disease

France
AstraZeneca

Completed

Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Maintenance Treatment)

Reflux Esophagitis

Japan
AstraZeneca

Completed

Quality of Life in Schizophrenic Patients (Quality)

Schizophrenia

Belgium
AstraZeneca

Completed

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer (TIME 2 CHANGE)

Breast Cancer | Post Menopausal

Italy
AstraZeneca

Completed

Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide

Advanced Prostate Cancer

Croatia
AstraZeneca

Completed

Local Phase 4 Pan-European SMART Study

Asthma

Italy, Sweden, France, Russian Federation, Spain, United Kingdom, Germany, Finland, Norway, Belgium, Netherlands, Greece, Ireland, Iceland

3

Subscribe